These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6124625)

  • 1. Effects of antidepressant drugs on dopamine uptake and metabolism.
    Waldmeier PC
    J Pharm Pharmacol; 1982 Jun; 34(6):391-4. PubMed ID: 6124625
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute choline administration in rat and mouse: no effect on dopamine metabolism in brain.
    Flentge F; Postema F; Medema HM; Van den Berg CJ
    Life Sci; 1981 Jul; 29(4):331-5. PubMed ID: 7278490
    [No Abstract]   [Full Text] [Related]  

  • 3. CNS dopamine autoreceptors: distribution, pharmacology, and function.
    Roth RH
    Ann N Y Acad Sci; 1984; 430():27-53. PubMed ID: 6378032
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K; Unemi N; Segawa T
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic influence of a 8 alpha-amino ergoline, CU 32-085, on striatal dopamine synthesis and turnover in vivo in the rat.
    Enz A
    Life Sci; 1981 Nov; 29(21):2227-34. PubMed ID: 6119592
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of amantadine and amfonelic acid on dopamine metabolism in rat brain.
    Fuller RW; Snoddy HD; Perry KW
    Brain Res Bull; 1981 Feb; 6(2):141-3. PubMed ID: 7470959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-dependent responsiveness to nonamphetamine central stimulants. Relationship between uptake and release of brain dopamine.
    McMillen BA; Shore PA
    Pharmacology; 1979; 19(5):261-6. PubMed ID: 43984
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists.
    Waldmeier PC; Ortmann R; Bischoff S
    Experientia; 1982 Oct; 38(10):1168-76. PubMed ID: 6128245
    [No Abstract]   [Full Text] [Related]  

  • 9. ATP induces release of newly synthesized dopamine in the rat striatum.
    Zhang YX; Yamashita H; Ohshita T; Sawamoto N; Nakamura S
    Neurochem Int; 1996 Apr; 28(4):395-400. PubMed ID: 8740447
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain catecholamine content and turnover in aging rats.
    Carfagna N; Trunzo F; Moretti A
    Exp Gerontol; 1985; 20(5):265-9. PubMed ID: 4092759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H; Jonsson G
    Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic amphetamine administration on dopaminergic systems in the vervet brain: relationship to findings in the brains of schizophrenics.
    Owen F; Baker HF; Ridley RM; Cross AJ; Crow TJ
    Biochem Soc Trans; 1983 Jan; 11(1):68-9. PubMed ID: 6131000
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of [3H]mazindol binding sites in rat striatum by dopaminergic agents.
    Ikawa K; Watanabe A; Kaneno S; Toru M
    Eur J Pharmacol; 1993 Dec; 250(2):261-6. PubMed ID: 7906653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of dopamine metabolism in rat brain, assessed by the influence of drugs [proceedings].
    Dedek J; Gomeni R; Korf J
    Arch Int Physiol Biochim; 1979 Oct; 87(4):794-5. PubMed ID: 93908
    [No Abstract]   [Full Text] [Related]  

  • 17. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    Life Sci; 1978 Aug; 23(6):611-5. PubMed ID: 692284
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine.
    Mignot E; Laude D
    J Neurochem; 1985 Nov; 45(5):1527-33. PubMed ID: 2864397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and serotonin turnover rate in the retina of rabbit, rat, goldfish, and Eugerres plumieri: light effects in goldfish and rat.
    Lima L; Urbina M
    J Neurosci Res; 1994 Dec; 39(5):595-603. PubMed ID: 7534358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine.
    Reches A; Hassan MN; Jackson VR; Fahn S
    Life Sci; 1983 Jul; 33(2):157-60. PubMed ID: 6865653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.